The Technology Innovation Hub (TIH) at IIT Bombay, under the Department of Science and Technology (DST), has successfully concluded ATMAN 3.0, its eight-week accelerator program aimed at transubstantiating early-stage HealthTech startups into investment-ready businesses. ATMAN 3.0, a flagship action of IIT Bombay, drew participation from across India, with 173 HealthTech startups pitching innovative results to the mecca. After a rigorous selection and mentoring process, six startups surfaced as winners, each set to admit up to INR 1 crore in seed backing, bringing the total accretive investment to INR 6 crore. The program’s successful capstone reinforces IIT Bombay’s commitment to supporting groundbreaking healthcare invention and scaling transformative results. 

The ATMAN 3.0 accelerator has deposited IIT Bombay as a crucial mecca for nurturing HealthTech startups. By offering mentorship, access to industry experts, and investor networks, the program ensures that innovative healthcare results aren’t only feasible but also scalable for real-world impact. With the rapid-fire growth of digital healthcare technologies in India, ATMAN 3.0 highlights the nation’s eventuality to become a global leader in healthcare invention. Authors were guided through technology confirmation, nonsupervisory compliance, investor readiness, and strategic assiduity connections, empowering them to strengthen their startups for sustainable growth. 

limelight on winning startups 

The six startups named from the final cohort of 13 accelerated gambles bring forward a different range of healthcare inventions. Prezitech Health Pvt Ltd introduced Precigo, a snap-on needle shadowing system for ultrasound machines designed to help high-perfection medical interventions. Attox Research Laboratories Pvt Ltd developed AMRIT, a result to combat antimicrobial resistance, addressing a critical global health challenge. Queliz Lifetech Pvt Ltd showcased UltraHand, a robotic recuperation device, while Deepfacts Private Ltd presented proRITHM, an AI-powered remote case monitoring platform using a compact wearable device to track vital signs in real time. MicroHeal and Raycura Medical Technologies brought forward BETTER, a recuperation device to support stroke and palsy recovery. Each of these startups demonstrates the implicit desire to ameliorate patient issues while using advanced technology to streamline healthcare delivery. 

Expert perceptivity and industry perspectives 

The program’s rally day, which brought together investors, healthcare leaders, and policymakers, featured a keynote address by Mr. Dileep Mangsuli, Chairman of Cancer Treatment Services International and Senior Vice President at Siemens Healthineers. He emphasized the transformative part of artificial intelligence in early complaint webbing and forestallment, noting that the future of healthcare relies on delivering quality care at scale across topographies. Mr. Mangsuli also outlined three foundational pillars for healthcare metamorphosis case twinning for personalized care, a perfect remedy to ameliorate clinical issues, and intelligent use of digital data to support timely clinical decision-making. His perceptivity reverberated with the startups and investors, pressing how innovative HealthTech results can address critical gaps in the healthcare ecosystem. 

Opining on the success of the accelerator, Mr. Kiran Shesh, CEO of TIH IIT Bombay, stated that ATMAN 3.0 is further than a traditional accelerator; it is a movement aimed at converting bold ideas into scalable, world-class healthcare results. “This cohort reflects India’s fleetly evolving healthcare ecosystem, showcasing inventions that are bigger, bolder, and unborn-focused,” he said. Mr. Shesh stressed the program’s emphasis on sustainability, deep technology, and global competitiveness, emphasizing that access to mentorship, sphere experts, and strategic investors equips authors to produce results that truly matter. 

Hardik Joshi, COO of TIH IIT Bombay, added that the accelerator provides a comprehensive frame for incipiency growth, beyond just funding. From technology confirmation and nonsupervisory guidance to investor readiness and assiduity connections, the program strengthens the foundations of startups to ensure long-term sustainability. The robust participation of investors and ecosystem stakeholders during Demo Day reflected the applicability and readiness of the graduating startups. 

Bridging Research and Commercialization 

ATMAN 3.0 also served as a platform for conversations on arising healthcare investment trends, evolving nonsupervisory fabrics, and new technology models shaping the future of the sector. The event encouraged portfolio startups from former TIH IIT Bombay programs to connect with investors for follow-on backing and strategic hookups. Devoted networking spaces eased meaningful dialogue between authors, investors, and industry stakeholders, fostering collaboration and implicit solidarity across the healthcare ecosystem. 

By successfully concluding ATMAN 3.0, TIH IIT Bombay continues to strengthen its part as a ground between slice-edge exploration and commercialization. The accelerator reinforces IIT Bombay’s position as a crucial enabler of scalable, impact-driven healthcare invention in India, empowering entrepreneurs to address critical healthcare challenges through technology and creativity. With the uninterrupted growth of programs like ATMAN, the mecca is set to accelerate India’s trip toward becoming a global leader in HealthTech results.

Share on Facebook

Post on X

Follow us

Save